Utility and applications of orthotopic models of human non-small cell lung cancer (NSCLC) for the evaluation of novel and emerging cancer therapeutics

Current Protocols in Pharmacology

Volumn 1, Issue SUPPL.62, 2013, Pages

  Justilien, Verline ^a   Fields, Alan P ^a  

^a MAYO CLINIC   (United States)

Author keywords

Bioluminescent in vivo imaging; Non small cell lung cancer; Orthotopic model

Indexed keywords

AURANOFIN; CEDIRANIB; CISPLATIN; PACLITAXEL; SELUMETINIB;

ARTICLE; CLINICAL FEATURE; HUMAN; IN VIVO STUDY; LUNG NON SMALL CELL CANCER; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 84896350321     PISSN: 19348282     EISSN: 19348290     Source Type: Journal    
DOI: 10.1002/0471141755.ph1427s62     Document Type: Article

References (26)

1. Boehle, A.S., Dohrmann, P., Leuschner, I., Kalthoff, H., and Henne-Bruns, D. 2000. An improved orthotopic xenotransplant procedure for human lung cancer in SCID bg mice. Ann. Thorac. Surg. 69:1010-1015.
2. Doki, Y., Murakami, K., Yamaura, T., Sugiyama, S., Misaki, T., and Saiki, I. 1999. Mediastinal lymph node metastasis model by orthotopic intrapulmonary implantation of Lewis lung carcinoma cells in mice. Br. J. Cancer 79: 1121-1126.
3. Erdogan, E., Lamark, T., Stallings-Mann, M., Jamieson, L., Pellechia, M., Thompson, E.A., Johansen, T, and Fields,A.P. 2006. Aurothiomalate inhibits transformed growth by targeting the PB1 domain of protein kinase Ciota. J. Biol. Chem. 38:28450-28459.
4. Frederick, L.A., Matthews, J.A., Jamieson, L., Justilien, V., Thompson, E.A., Radisky, D.C., and Fields, A.P. 2008. Matrix metalloproteinase-10 is a critical effector of protein kinase Ciota-Par6alpha-mediated lung cancer. Oncogene 27:4841-4853.
5. Goto, H., Yano, S., Zhang, H., Matsumori, Y., Ogawa, H.,Blakey, D.C., and Sone, S. 2002. Activity of a newvascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinoma in nude mice. Cancer Res. 62:3711-3715.
6. Grossman, C.E., Pickup, S., Durham, A., Wileyto, E.P., Putt, M.E., and Busch, T.M. 2011. Photodynamic therapy of disseminated non-small cell lung carcinoma in a murine model. Lasers Surg. Med. 43:663-675.
7. Janne, P.A., Shaw, A.T., Pereira, J.R., Jeannin, G., Vansteenkiste, J., Barrios, C., Franke, F.A., Grinsted, L., Zazulina, V., Smith, P., Smith, I., and Crino, L. 2013. Selumetinib plus docetaxel for KRAS-mutant advanced non-smallcell lung cancer: A randomised, multicentre, placebo-controlled, phase 2 study. Lancet Oncol. 14:38-47.
8. Jin, H., Yang, R., Ross, J., Fong, S., Carano, R., Totpal, K., Lawrence, D., Zheng, Z., Koeppen, H., Stern, H., Schwall, R., and Ashkenazi, A. 2008. Cooperation of the agonistic DR5 antibody apomab with chemotherapy to inhibit orthotopic lung tumor growth and improve survival. Clin. Cancer Res. 14:7733-7740.
9. Justilien, V. and Fields, A. P. 2009. Ect2 links the PKC?-Par6a complex to Rac1 activation and cellular transformation. Oncogene 41:3597-3607.
10. Justilien, V., Regala, R.P., Tseng, I.C., Walsh, M.P., Batra, J., Radisky, E.S.,Murray, N.R., and Fields, A.P. 2012. Matrix metalloproteinase-10 is required for lung cancer stem cell maintenance, tumor initiation and metastatic potential. PLoS One 7:e35040.
11. Killion, J.J., Radinsky, R., and Fidler, I.J. 1998. Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Rev. 17:279-284.
12. Liu, X., Liu, J., Guan, Y., Li, H., Huang, L., Tang, H., and He, J. 2012. Establishment of an orthotopic lung cancer model in nude mice and its evaluation by spiral CT. J. Thorac. Dis. 4:141-145.
13. Madero-Visbal, R.A., Colon, J.F., Hernandez, I.C., Limaye, A., Smith, J., Lee, C.M., Arlen, P.A., Herrera, L., and Baker, C.H. 2012. Bioluminescence imaging correlates with tumor progression in an orthotopic mouse model of lung cancer. Surg. Oncol. 21:23-29.
14. Mclemore, T.L., Liu, M.C., Blacker, P.C., Gregg, M., Alley, M.C., Abbott, B.J., Shoemaker, R.H., Bohlman, M.E., Litterst, C.C., Hubbard, W.C., Brennan, R.H., Mcmahon, J.B., Fine, D.L., Eggleston, J.C., Mayo, J.G., and Boyd, M.R. 1987. Novel intrapulmonary model for orthotopic propagation of human lung cancers in athymic nude mice. Cancer Res. 47: 5132-5140.
15. Mclemore, T.L., Eggleston, J.C., Shoemaker, R.H., Abbott, B.J., Bohlman, M.E., Liu, M.C., Fine, D. L., Mayo, J.G., and Boyd, M.R. 1988. Comparison of intrapulmonary, percutaneous intrathoracic, and subcutaneous models for the propagation of human pulmonary and nonpulmonary cancer cell lines in athymic nude mice. Cancer Res. 48:2880-2886.
16. Moodie, S.A., Willumsen, B.M., Weber, M.J., and Wolfman, A. 1993. Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase. Science 260:1658-1661.
17. Mordant, P., Loriot, Y., Lahon, B., Castier, Y., Leseche, G., Soria, J.C., Vozenin, M.C., Decraene, C., and Deutsch, E. 2011. Bioluminescent orthotopic mouse models of human localized non-small cell lung cancer: feasibility and identification of circulating tumour cells. PLoS One 6:e26073.
18. Onn, A., Isobe, T., Itasaka, S., Wu, W., O'Reilly, M.S., Ki Hong,W., Fidler, I.J., and Herbst, R.S. 2003. Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice. Clin. Cancer Res. 9:5532-5539.
19. Perez-Soler, R., Kemp, B., Wu, Q.P., Mao, L., Gomez, J., Zeleniuch-Jacquotte, A., Yee, H., Lee, J.S., Jagirdar, J., and Ling, Y.H. 2000. Response and determinants of sensitivity to paclitaxel in human non-small cell lung cancer tumors heterotransplanted in nude mice. Clin. Cancer Res. 6:4932-4938.
20. Ramalingam, S. and Belani, C. 2008. Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions. Oncologist 13:S5-S13.
21. Regala, R.P., Weems, C., Jamieson, L., Khoor, A., Edell, E.S., Lohse, C.M., and Fields, A.P. 2005. Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer. Cancer Res. 65:8905-8911.
22. Shimkin, M.B. and Stoner, G.D. 1975. Lung tumors in mice: application to carcinogenesis bioassay. Adv. Cancer Res. 21:1-58.
23. Siegel, R., Naishadham, D., and Jemal, A. 2012. Cancer statistics, 2012. CA Cancer J. Clin. 62:10-29.
24. Stallings-Mann, M., Jamieson, L., Regala, R.P., Weems, C., Murray, N.R., and Fields, A.P. 2006. A novel small-molecule inhibitor of protein kinase Cl blocks transformed growth of non-small-cell lung cancer cells. Cancer Res. 66:1767-1774.
25. Takahashi, O., Komaki, R., Smith, P.D., Jurgensmeier, J.M., Ryan, A., Bekele, B.N., Wistuba, I.I., Jacoby, J.J., Korshunova, M.V., Biernacka, A., Erez, B.,Hosho, K., Herbst, R.S., and O'Reilly, M.S. 2012. Combined MEK and VEGFR inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasis. Clin. Cancer Res. 18:1641-1654.
26. Wang, H.Y., Ross, H.M., Ng, B., and Burt, M.E. 1997. Establishment of an experimental intrapulmonary tumor nodule model. Ann. Thorac. Surg. 64:216-219.